ROSENWALD LINDSAY A MD — SEC insider filings
SEC reporting owner CIK 941841. 48 insider filings on record with FilingPulse; latest filed 2026-11-19.
Transaction summary — filings shown
Covers all 48 filings on record, filed 2020-08-19 to 2026-11-19. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 27 legs across 23 filings — 6,023,075 shares, $9,036,718 total (shares × price as filed).
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 40.
- Largest priced transaction: purchase of 1,567,515 shares @ $1.70 ($2,664,776) in Fortress Biotech, Inc., filed 2023-11-16.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Fortress Biotech, Inc. (FBIO) | PRESIDENT, CEO & CHAIRMAN, Director, 10% owner | 22 | 19 legs · 5,335,306 sh · $7,926,665 | — | 15 |
| MUSTANG BIO, INC. (MBIO) | Director | 9 | 4 legs · 209,094 sh · $537,607 | — | 9 |
| Journey Medical Corp (DERM) | Director | 8 | 3 legs · 130,000 sh · $321,400 | — | 5 |
| AVENUE THERAPEUTICS, INC. (ATXI) | Director | 3 | 1 leg · 348,675 sh · $251,046 | — | 2 |
| Checkpoint Therapeutics, Inc. (CKPT) | Director | 6 | — | — | 9 |
Insider filings — ROSENWALD LINDSAY A MD
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-11-19 | 4 | Fortress Biotech, Inc. (FBIO) | Purchase (P): 64,491 @ $1.80 · Purchase (P): 54,776 @ $1.90 · Purchase (P): 17,456 @ $1.86 | EDGAR |
| 2026-06-26 | 4 | Journey Medical Corp (DERM) | Grant/award (A): 10,000 @ $0 | EDGAR |
| 2026-03-20 | 4 | Fortress Biotech, Inc. (FBIO) | Grant/award (A): 475,424 @ $0 | EDGAR |
| 2025-08-07 | 4 | Journey Medical Corp (DERM) | Grant/award (A): 50,000 @ $0 | EDGAR |
| 2025-07-07 | 4 | Journey Medical Corp (DERM) | Grant/award (A): 7,173 @ $0 | EDGAR |
| 2025-05-30 | 4 | Checkpoint Therapeutics, Inc. (CKPT) | Grant/award (A): 12,195 @ $0 · Grant/award (A): 50,000 @ $1.29 · Code (U): 207,007 | EDGAR |
| 2025-01-03 | 4 | Fortress Biotech, Inc. (FBIO) | Grant/award (A): 454,153 @ $0 | EDGAR |
| 2024-12-17 | 4 | Checkpoint Therapeutics, Inc. (CKPT) | Grant/award (A): 12,638 @ $0 | EDGAR |
| 2024-09-25 | 4 | Fortress Biotech, Inc. (FBIO) | Purchase (P): 763,359 @ $1.84 · Purchase (P): 763,359 (derivative) @ $0.12 | EDGAR |
| 2024-09-25 | 4 | AVENUE THERAPEUTICS, INC. (ATXI) | Grant/award (A): 30,000 (derivative) @ $0 | EDGAR |
| 2024-07-15 | 4 | Fortress Biotech, Inc. (FBIO) | Purchase (P): 5,000 @ $7.48 | EDGAR |
| 2024-07-11 | 4 | Fortress Biotech, Inc. (FBIO) | Purchase (P): 5,000 @ $7.39 | EDGAR |
| 2024-07-10 | 4 | Fortress Biotech, Inc. (FBIO) | Purchase (P): 5,000 @ $7.35 | EDGAR |
| 2024-07-10 | 4 | Journey Medical Corp (DERM) | Grant/award (A): 9,728 @ $0 | EDGAR |
| 2024-07-01 | 4 | Fortress Biotech, Inc. (FBIO) | Purchase (P): 20,000 @ $1.64 | EDGAR |
| 2024-05-20 | 4 | Fortress Biotech, Inc. (FBIO) | Purchase (P): 10,000 @ $1.76 | EDGAR |
| 2024-05-16 | 4 | Checkpoint Therapeutics, Inc. (CKPT) | Grant/award (A): 32,051 @ $0 · Grant/award (A): 50,000 @ $0 | EDGAR |
| 2024-03-27 | 4 | Journey Medical Corp (DERM) | Purchase (P): 10,000 @ $3.04 | EDGAR |
| 2024-03-25 | 4 | Journey Medical Corp (DERM) | Purchase (P): 20,000 @ $3.40 | EDGAR |
| 2024-01-09 | 4 | Fortress Biotech, Inc. (FBIO) | Purchase (P): 50,000 @ $2.38 | EDGAR |
| 2024-01-03 | 4 | Fortress Biotech, Inc. (FBIO) | Grant/award (A): 216,465 @ $0 | EDGAR |
| 2023-11-16 | 4 | Fortress Biotech, Inc. (FBIO) | Purchase (P): 1,567,515 @ $1.70 · Purchase (P): 1,567,515 (derivative) @ $0 | EDGAR |
| 2023-09-27 | 4 | Fortress Biotech, Inc. (FBIO) | Purchase (P): 100,000 @ $0.28 | EDGAR |
| 2023-09-12 | 4 | AVENUE THERAPEUTICS, INC. (ATXI) | Purchase (P): 348,675 @ $0.72 | EDGAR |
| 2023-09-08 | 4 | Journey Medical Corp (DERM) | Purchase (P): 100,000 @ $2.23 | EDGAR |
| 2023-08-21 | 4 | Fortress Biotech, Inc. (FBIO) | Purchase (P): 10,000 @ $11.75 · Purchase (P): 10,000 @ $9.34 | EDGAR |
| 2023-07-07 | 4 | MUSTANG BIO, INC. (MBIO) | Grant/award (A): 7,246 @ $0 | EDGAR |
| 2023-07-05 | 4 | AVENUE THERAPEUTICS, INC. (ATXI) | Grant/award (A): 100,000 (derivative) @ $0 | EDGAR |
| 2023-06-15 | 4 | Checkpoint Therapeutics, Inc. (CKPT) | Grant/award (A): 17,483 @ $0 | EDGAR |
| 2023-04-03 | 4 | MUSTANG BIO, INC. (MBIO) | Purchase (P): 4,094 @ $0.74 · Grant/award (A): 71,664 @ $0 · Purchase (P): 5,000 @ $0.52 | EDGAR |
| 2023-02-14 | 4 | Fortress Biotech, Inc. (FBIO) | Purchase (P): 2,395,209 @ $0.83 | EDGAR |
| 2023-01-04 | 4 | Fortress Biotech, Inc. (FBIO) | Grant/award (A): 4,264 @ $0.73 · Grant/award (A): 1,219,294 @ $0 | EDGAR |
| 2022-12-05 | 4 | Fortress Biotech, Inc. (FBIO) | Purchase (P): 100,000 @ $0.68 | EDGAR |
| 2022-12-02 | 4 | Fortress Biotech, Inc. (FBIO) | Purchase (P): 5,000 @ $0.56 | EDGAR |
| 2022-10-24 | 4 | Fortress Biotech, Inc. (FBIO) | Purchase (P): 100,000 @ $0.69 | EDGAR |
| 2022-07-25 | 4 | Journey Medical Corp (DERM) | Grant/award (A): 14,245 @ $0 | EDGAR |
| 2022-06-24 | 4 | Checkpoint Therapeutics, Inc. (CKPT) | Grant/award (A): 47,619 @ $0 | EDGAR |
| 2022-04-29 | 4 | Fortress Biotech, Inc. (FBIO) | Grant/award (A): 1,297 @ $2.31 · Other (J): 8,133 @ $0 · Other (J): 4,619 @ $0 · Grant/award (A): 1,250 @ $2.42 · Grant/award (A): 1,102,986 @ $0 | EDGAR |
| 2021-09-24 | 4 | MUSTANG BIO, INC. (MBIO) | Grant/award (A): 1,170 @ $2.58 | EDGAR |
| 2021-07-08 | 4 | MUSTANG BIO, INC. (MBIO) | Grant/award (A): 13,774 @ $0 | EDGAR |
| 2021-06-11 | 4 | Checkpoint Therapeutics, Inc. (CKPT) | Grant/award (A): 16,502 @ $0 | EDGAR |
| 2021-04-09 | 4 | Fortress Biotech, Inc. (FBIO) | Grant/award (A): 1,602 @ $1.69 · Grant/award (A): 1,250 @ $2.34 · Grant/award (A): 1,030,339 @ $0 | EDGAR |
| 2021-03-15 | 4 | MUSTANG BIO, INC. (MBIO) | Grant/award (A): 1,043 @ $2.83 | EDGAR |
| 2020-12-22 | 4/A | MUSTANG BIO, INC. (MBIO) | Grant/award (A): 831 @ $2.48 · Grant/award (A): 16,611 @ $2.48 | EDGAR |
| 2020-12-22 | 4/A | MUSTANG BIO, INC. (MBIO) | Grant/award (A): 1,182 @ $2.48 · Purchase (P): 100,000 @ $2.66 | EDGAR |
| 2020-12-15 | 4 | MUSTANG BIO, INC. (MBIO) | Purchase (P): 100,000 @ $2.66 | EDGAR |
| 2020-09-01 | 4 | Fortress Biotech, Inc. (FBIO) | Purchase (P): 52,500 @ $18 | EDGAR |
| 2020-08-19 | 4 | MUSTANG BIO, INC. (MBIO) | Grant/award (A): 16,611 @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2020-08-18 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=941841 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs